| 000 | 01666 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516170657.0 | ||
| 264 | 0 | _c20140416 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1878-5905 | ||
| 024 | 7 |
_a10.1016/j.biomaterials.2013.08.032 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHong, Wei | |
| 245 | 0 | 0 |
_aReversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers. _h[electronic resource] |
| 260 |
_bBiomaterials _cDec 2013 |
||
| 300 |
_a9602-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibiotics, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aBreast _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xchemistry |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Resistance, Multiple _xdrug effects |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHistidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMicelles |
| 650 | 0 | 4 |
_aPoloxamer _xadministration & dosage |
| 650 | 0 | 4 |
_aPolyesters _xchemistry |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xchemistry |
| 700 | 1 | _aChen, Dawei | |
| 700 | 1 | _aZhang, Xiaojun | |
| 700 | 1 | _aZeng, Jianfu | |
| 700 | 1 | _aHu, Haiyang | |
| 700 | 1 | _aZhao, Xiuli | |
| 700 | 1 | _aQiao, Mingxi | |
| 773 | 0 |
_tBiomaterials _gvol. 34 _gno. 37 _gp. 9602-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.biomaterials.2013.08.032 _zAvailable from publisher's website |
| 999 |
_c23074734 _d23074734 |
||